Peptide Therapy Marketing · LL-37

LL-37 Marketing Strategy for Peptide Clinics

Written byTamerlan Musayev·Founder of PeptideLeads

LL-37 is one of the most promising peptides for chronic infection and immune patients but it is also one of the trickiest to market because of compliance requirements. PeptideLeads was built by founder Tamerlan Musayev to handle exactly these categories. This page describes how we think about LL-37 marketing strategy.

The Market Context

The LL-37 audience is usually deep in the chronic illness community. They talk to each other in Facebook groups and Reddit forums. Word of mouth matters more in this category than in most, which means the clinics that build real reputations capture more referrals than the ones that just run ads.

Why This Works

A community-aware strategy works because these patients trust each other more than they trust marketing. We build campaigns that respect that reality.

How Our Process Works

Audit, landing pages, creative, compliant campaigns, leads. Ad spend covered. $50 per qualified lead.

What Makes Us Different

We understand the chronic illness audience and the compliance landscape.

$50 Per Lead. No Retainer. We Cover All Ad Spend.

Ready to build an LL-37 program? Book a call.

Book a 30-Minute Call Get Matched

Frequently Asked Questions

How do I build trust with chronic illness patients?

Visible provider credentials, clear protocols, and honest expectations.

Is word of mouth important?

Yes. More than in most peptide categories.

Is creative included?

Yes.

Is there a contract?

No.

How long until results?

Lead flow within 7 to 14 days.